A study conducted by Alsugair et al
This agent is currently in phase 1b trials
Berberine, an alkaloid extracted from traditional Chinese medicine, binds to the bitter taste receptor TAS2R38 and activates the PLC signaling pathway to stimulate GLP-1 secretion in STC-1 cells [193]
Medicare currently only covers these drugs for people who are diagnosed with diabetes or cardiovascular disease with obesity, or for people who are overweight, according to the official, who added that while some state Medicaid programs cover the GLP-1 medications for obesity, many do not
Most people taking GLP-1 or dual GIP-GLP-1 medication experience few side effects
This makes it effective in managing conditions such as high blood pressure, angina, heart failure, and certain irregular heart rhythms